Ligand validation:6GPJ

G4F: [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{S},6~{R})-5-fluoranyl-6-(hydroxymethyl)-3,4-bis(oxidanyl)oxan-2-yl] hydrogen phosphate

G4F is a Ligand Of Interest in 6GPJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GPJ_G4F_B_403	91%	32%	0.083	0.971	0.98	1.83	3	6	0	0	100%	1
6GPJ_G4F_A_402	91%	32%	0.083	0.969	1.06	1.75	3	6	0	0	100%	1
6GPJ_G4F_D_402	89%	31%	0.087	0.967	1.08	1.75	2	5	0	0	100%	1
6GPJ_G4F_C_401	86%	31%	0.092	0.96	1	1.84	2	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.